DaVita Kidney Care’s Post

On International Cancer Day, Roche stands at the forefront of a global mission – a collective commitment to #ClosingTheCareGap in #CancerCare. World Health Organization estimates that cancer leads to nearly 459,000 deaths each year in the Eastern Mediterranean Region. Over the past five years, around 1.6 million people in the region have faced this ongoing challenge. It places a heavy burden, both physically and emotionally, on individuals, families, and communities. Annually, approximately 734,000 individuals receive a cancer diagnosis, and by 2040, it's expected that this number will rise by about 50%*. As part of our mission, we recognize the crucial role a holistic care approach plays in bridging the gap for individuals living with cancer. We must take into account a range of aspects that contribute to a patient's well-being, including mental health, spiritual needs, and overall quality of life. Through this approach, we aim to ensure that every cancer patient is met with personalized care that extends beyond medical aspects to enhance their overall well-being. In Egypt, Roche’s collaboration with the Egyptian Government on a Breast Cancer presidential initiative was created through a shared vision to ensure equal access to the highest global standard of care regardless of social status. Roche provided support for early detection through screening and diagnosis, building laboratory capability and capacity and establishing Multi-Disciplinary Teams for better patient management. Over a three-year period, the collaboration led to more than 29 million women screened with a 50% decrease in advanced stage breast cancer. Furthermore, we've signed an MOU to collaborate with the Qatar Foundation focusing on enhancing the country's capabilities for personalized healthcare. We are actively supporting the capacity building of the Qatar Cancer Society by conducting awareness campaigns on personalized care. And we're assisting in developing their expertise in innovation and design thinking while aiding in processing patients' financial support requests. In Saudi Arabia, we are working with King Faisal Specialist Hospital and Research Center to develop the capabilities and infrastructure to carry out advanced testing for patients living with cancer, including Next-Generation Sequencing (NGS) and Comprehensive Genomic Profiling (CGP). This testing is a vital step towards enabling more personalized approaches to cancer treatment. I personally believe that achieving progress in cancer care is a shared responsibility among multiple stakeholders. Therefore, we must engage in joint efforts to continue to address the challenges. We are commited to fostering innovative solutions and inclusive approaches aimed at improving the accessibility, effectiveness, and equality of cancer care for patients. #AccessToInnovation #accesstohealthcare * https://lnkd.in/dMjaRnG2

This year’s #WorldCancerDay is focused on taking meaningful action to #CloseTheCareGap and ensure everyone has access to the quality cancer care they need. Thank you @Joerg-Michael Rupp for shining a light on some of the ways #Roche and our partners are working towards this goal – on World Cancer Day and every day.  As advances in science and technology make new and better ways of diagnosis, treating and even curing cancer possible, one of the key challenges the oncology community faces is how we scale up these advances in care so they can benefit everyone who needs them. This is essential for closing the care gap and improving outcomes for the millions of people diagnosed with cancer each year in Europe and beyond.  This is why initiatives like OnkoAlliance Slovensko are so important. Slovakia has the second highest mortality rate from cancer in the EU (read more). OnkoAlliance Slovensko was co-founded by Roche to bring together patient organisations, experts and the biotech industry to take action to support the implementation of  Europe’s Beating Cancer Plan in Slovakia. The alliance has generated discussion about equal access to treatment and diagnosis and facilitated exchanges between EU-level experts and national policy- and decision-makers. Furthermore, OnkoAlliance is about to publish a study on the economic benefits of early disease intervention and is partnering with the local Health Ministry to pilot the usage of AI in optimising patient flows to shorten wait times on the patient journey. OnkoAlliance is just one inspirational example of the powerful impact shared ambition and collaboration can have. I urge others working on national cancer plans to join forces across borders and sectors to #CloseTheCareGap and create a world where everyone, everywhere has access to the best possible cancer care. Together, we can make a truly meaningful difference.  #CloseTheCareGap #CancerCare #Partnership #Innovation #ValueofInnovation 

🎉 Big News! 🎉 We are thrilled to announce the launch of our refreshed brand identity! 🚀 Take a moment to check it out and let us know what you think. Your feedback means a lot! #Rebrand #NewLook #ExcitingTimes #slp #slplife #ot #school #schoolleadership

Explaining Alzheimer’s disease to children can be difficult, but if you're a caregiver for a loved one with Alzheimer's and have children, it can be a necessity. This short film by CAN supporter Otsuka Pharmaceutical Companies (U.S.) is working to support caregivers in their journey. Watch here: https://bit.ly/3usasbK #EndALZ #Caregiving #CaregiverSupport

🌟 Strength in Community: Empowering Post Kidney Transplant Individuals 🌟 We recognize the importance of community in every stage/phase of life and that is why we at the Arike Kidney Foundation have come together to create a community for post-kidney transplant individuals. In our community, we find solace, support, and shared experiences. 💚 🤝 Together We Thrive: Our community is a source of strength and resilience. We uplift each other through the highs and lows, knowing that no one walks alone. 💬 Shared Stories, Shared Strength: In our shared experiences lie invaluable lessons and unwavering support. Every story shared enriches our collective journey. 🌱 Nurturing Growth: Through encouragement and understanding, we nurture growth and inspire hope. Together, we embrace the possibilities of life post-transplant. 👏 Celebrating Victories: From milestone anniversaries to everyday triumphs, we celebrate each other's victories, knowing the courage it takes to persevere. 💙 Connected by Hope: In our community, hope is our common thread. It binds us together, reminding us that brighter days are always within reach. Let's continue to uplift, inspire, and support one another on this incredible journey. Together, we're stronger. Together, we thrive. 💪🌟 #CommunitySupport #PostKidneyTransplantJourney #StrengthInUnity #PostKidneyTransplantLife

Want to learn more about hospice and ViaQuest Hospice? Check out our weekly hospice trivia questions as we celebrate National Hospice and Palliative Care Month!

WHAT WILL YOUR LEGACY BE? You can make a small change in your will leaving a gift to Emerge Australia creating a significant impact in helping us to deliver clinical education, patient support and patient education, advocacy and biomedical research for people with ME/CFS and Long COVID in Australia. Even a gift of 2% of your estate could empower Emerge Australia’s mission, while still letting you provide financially for your loved ones. If you’ve already prepared your will, and would like to pledge a gift to Emerge Australia, we recommend some simple steps that you can see here: https://vist.ly/uphi Everyone has the power to create incredible legacy - including you!

Excellent Video! Take a look... The leadership and advocacy by the National Kidney Foundation is essential, pivotal and very much appreciated. The 4th silo ("other entities" i.e. Patient Stakeholders) need voices. Your plan articulates the essential changes that were stated in the last paragraph of the Preface to the NASEM Report. "As requested in the study charge, the committee also considered the Organ Procurement and Transplantation Network (OPTN) policy-making process and opportunities for improving it. While the steps in the general policy-making process are well documented, the dynamics of the OPTN committee interactions and the true impact on final policies was not always clear. The OPTN is not alone in its efforts to work with a broad range of stakeholders to craft policies to complicated and contentious issues in health care and the policy-making process for organ procurement, allocation, and distribution should be informed by the expertise and experience of other entities. Overall, we are confident system improvement is possible and are hopeful for the future." Dr. Ken Kizer, Chairman #NKF #organdonation #organtransplant #transparency #data #accountability #patientadvocacy #reform

In honor of Doctors’ Day, we celebrate Samuel Kimura, MD, and Michael Hogan, MD, founders of That Man May (now All May See) Foundation in 1971. Learn more about them and support this important work at www.allmaysee.org! #DoctorsDay2024 #UCSF #UCSFOphthalmology